Cti Biopharma reported $61.71M in Equity Capital and Reserves for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Applied Genetic Technologies AGTC:US $ 85.81M 11.19M
Baxter International BAX:US $ 8494M 42M
Bristol Myers Squibb BMY:US $ 36808M 797M
Cti Biopharma CTIC:US $ 61.71M 35.05M
Cytori Therapeutics CYTX:US $ 11.94M 2.43M
Eli Lilly And LLY:US $ 6444.4M 454.3M
Geron GERN:US $ 176.21M 24.96M
Mirati Therapeutics MRTX:US $ 1128.92M 130.49M
Northwest Biotherapeutics NWBO:US -349842000 3.36M
Novartis NOVN:VX SF 54042M 3519M
Novartis NVS:US $ 54042M 3519M
Seattle Genetics SGEN:US $ 3391.27M 33.35M
Sunesis Pharmaceuticals SNSS:US $ 117.1M 7.65M
Teva Pharmaceutical Industries TEVA:US $ 10324M 324M
YTE INCY:US $ 2935.86M 208.02M